Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 5 minute read General business news Inside KKR’s Korea strategy: Why global private equity is chasing premium Korean manufacturers KKR’s USD 528M acquisition of Samhwa reveals a larger private equity play on South Korea’s premium mid-cap manufacturing base. Here’s what’s driving it. byPallavi MadhirajuSeptember 11, 2025